Diadem: Paul Kinnon

University of Brescia spinout Diadem has appointed Paul Kinnon its CEO. Kinnon was previously CEO of PredictImmune, Transgenomic, and Zygem. He has also held executive positions at Life Technologies, now part of Thermo Fisher Scientific, Guava Technologies, and Cellomics. Founded in 2012, Diadem is developing a blood-based test to predict early onset Alzheimer's disease. Its flagship test is AlzoSure, which measures conformational changes in the p-53 pathway by targeting unfolded p-53, which is overexpressed in Alzheimer's patients.